-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Sarepta Therapeutics, Lowers Price Target to $58

Benzinga·05/07/2025 17:37:38
Listen to the news
RBC Capital analyst Brian Abrahams maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Sector Perform and lowers the price target from $87 to $58.